Medical expert on Restylane

Restylane is newly approved by the FDA. Joshua Fox MD is available for interviews on Restylane.

(PRWEB) February 5, 2004--Medical expert available to talk about Restylane.

In December of 2003 the FDA approved Restylane, the newest agent for filling smile lines, enhancing lips, contouring facial features and reducing expression lines and folds around the face. Restylane is the first dermal filler made of crystal-clear gel that results in far longer duration of results than than the currently popular fillers such as Botox and collagen. Results from Restylane are expected to last for up to six months and sometimes more. The Restylane gel adds volume to minimize wrinkles and lines is injected right into the skin in tiny amounts with a very fine needle. The results are immediate. The cost of treatment can range between $500 - $750 per injection.

For reporters planning to write about Restylane or the larger trend in new and increasingly popular cosmetic treatments Joshua Fox MD. would be an excellent resource Dr. Fox is at the cutting edge of cosmetic surgery and laser procedures and has already begun using Restylane on patients in the NY Metropolitan area. I am certain that Dr. Fox would provide accurate and interesting input about Restylane and cosmetic treatements in general. Following is Dr. Fox's bio.

Bio Joshua Fox MD:

Joshua L. Fox, M.D. is a leading authority in the field of dermatology with an expertise in skin cancer, cosmetic surgery, and laser procedures. As an official spokesperson for the American Academy of Dermatology and the American Society of Dermatologic Surgery, Dr. Fox has been an expert resource on dermatologic topics for numerous television networks including ABC, CBS, CNN, NBC, Telemundo, talk shows, radio stations, newspapers and magazines. He has received multiple research and clinical awards including recognition from Top Doctors, Whos Who, Journal of Dermatologic Surgery and Oncology, Community Service Award from the American Society of Dermatologic Surgery, the prestigious Husic Award as well certificates of recognition for service from multiple hospitals, civic, educational and community organizations. Dr. Fox has authored and presented papers of his research on lasers, cosmetic procedures, stretch marks, scars, skin cancer, bug bites, photosensitivity and various rashes.

As founder and director of Advanced Dermatology and The Center for Laser and Cosmetic Surgery, Dr. Fox and associates have expanded the practice to the one of largest in dermatology, laser & cosmetic surgery with more lasers than any hospital or dermatology practice on the eastern coast. Dr. Fox is a graduate of the New York University Medical Center of Skin and Cancer and has been on the advisory board of the Psoriasis Foundation and National Rosacea Foundation among others. He has also been a fellow of many societies including the International Academy of Cosmetic Surgery, International Academy of Cosmetic Dermatology, and the Society for Investigative Dermatology. Dr. Fox is the founder of the AAD Melanoma/Skin Cancer Prevention Program in Queens, New York since 1987. Dr. Fox has been Chief of Dermatology of several major teaching hospitals including Mt. Sinai Hospital of Queens and Jamaica Medical Center and is currently on the staff of ten NY area hospitals. Dr. Fox and Advanced Dermatology the Center for Laser & Cosmetic Surgery have been used as a resource center educating dermatologists, laser surgeons, & cosmetic surgeons and others about lasers, cancer and cosmetic surgery.

Melissa Chefec

MCPR

203-968-6625

mchefec@optonline.net

###


Contact Information
Melissa Chefec
MCPR
http://www.advanceddermatologypc.com
203-968-6625

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy